The Innovation Dispatch

Life Sciences

2 articles

Editorial illustration for Where Intelligent Automation Actually Works in Drug Discovery and Clinical Trials
Industry Insights

Where Intelligent Automation Actually Works in Drug Discovery and Clinical Trials

Intelligent automation is proving effective in drug discovery, from lab analysis to preclinical modeling, and in clinical trials, streamlining design and monitoring. By automating repetitive tasks, it significantly increases throughput and efficiency, allowing human experts to focus on critical decision-making.

Omar Haddad·October 20, 2026
Representatives from Altaris Capital and Simulations Plus sealing a deal, symbolizing the acquisition and its impact on drug discovery software.
Software

Altaris Capital Buys Simulations Plus for $375 Million

Simulations Plus shareholders will receive $18.

Sophie Laurent·June 16, 2026